Ingrid Quist-Løkken

Stipendiat
ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Resultater Resultater

Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma.

Andersson-Rusch, Clara Leticia; Quist-Løkken, Ingrid; Sætrom, Pål; Beisvag, Vidar; Rolinski, Milosz; Aas, Per Arne; van Loon, Barbara; Holien, Toril. 2023, Blood. STOLAV, NTNUSammendrag/abstract

Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma.

Andersson-Rusch, Clara Leticia; Quist-Løkken, Ingrid; Sætrom, Pål; Beisvag, Vidar; Rolinski, Milosz; Møen, Johanna; Misund, Kristine; Aas, Per Arne; van Loon, Barbara; Holien, Toril. 2023, 65th ASH Annual Meeting and Exposition. STOLAV, NTNUPoster

Novel FKBP12 targeting PROTACs enhance BMP-induced apoptosis in multiple myeloma.

Quist-Løkken, Ingrid; Walz, Michael; Hausch, Felix; Holien, Toril. 2023, Clinical Lymphoma, Myeloma & Leukemia. STOLAV, NTNUSammendrag/abstract

Novel FKBP12 targeting PROTACs enhance BMP-induced apoptosis in multiple myeloma.

Quist-Løkken, Ingrid; Andersson-Rusch, Clara Leticia; Hanif, Md Abu; Tilseth, Mira-Celeste; Walz, Michael; Hausch, Felix; Holien, Toril. 2023, 20th International Myeloma Workshop. STOLAV, NTNUPoster

High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.

Andersson-Rusch, Clara Leticia; Liu, Bin; Quist-Løkken, Ingrid; Upton, Paul D.; Olsen, Oddrun Elise; Hella, Hanne; Yang, Xudong; Tong, Zhen; Morrell, Nicholas W.; Holien, Toril mfl.. 2023, Scientific Reports. STOLAV, UOC, NTNUVitenskapelig artikkel

1 - 5 av 12 | Neste | Siste »